8-K current report · filed Nov 10, 2026

Elevance Health (ELV) 8-K Current Report: November 10, 2026

Item 7.01ELV overview

Short answer

Elevance Health (ELV) filed an 8-K current report with the SEC on November 10, 2026 reporting Item 7.01 (Regulation FD Disclosure). 2026 shareholders’ earnings guidance reaffirmed at least $22.00 per diluted share.

Elevance Health 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • 2026 shareholders’ earnings guidance reaffirmed at least $22.00 per diluted share
  • Approximately $7.00 per diluted share of net unfavorable items included in reported guidance
  • Adjusted shareholders’ earnings guidance maintained at least $29.00 per diluted share
  • Benefit expense ratio guidance reaffirmed at 90.2%, plus or minus 50 basis points
  • Investor meetings this week provide a near-term confirmation of management’s outlook ahead of future results

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Elevance Health 8-K filings

Get the next ELV 8-K as it lands

Follow ELV for push alerts, or ask the research agent what this filing means.